Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010)

Alnylam Pharmaceuticals (ALNY) reported Current Taxes of $237000.0 for Q3 2010, down 12.87% quarter-over-quarter from $272000.0 in Q2 2010.

Alnylam Pharmaceuticals (ALNY) Current Taxes (2009 - 2010) Analysis & Trends

Alnylam Pharmaceuticals has reported Current Taxes for 2 years, with the latest figure at $237000.0 in Q3 2010.

For the quarter ending Q3 2010, Current Taxes changed N/A year-over-year to $237000.0; the trailing twelve-month figure through Sep 2010 stood at $237000.0 (changed N/A YoY), and the FY2009 full-year result was $5.5 million, changed N/A from the prior year.
Current Taxes for Q3 2010 stood at $237000.0, down from $272000.0 in the prior quarter.
The five-year high for Current Taxes was $5.5 million in Q4 2009, with the low at $237000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Alnylam Pharmaceuticals	37.04 Bn	34.03 Bn	959.66 Mn	-

Download Data